World Hepatitis Summit

November 1-3, 2017
São Paulo, Brazil

The World Hepatitis Summit is a large-scale, global biennial event with the goal of advancing the viral hepatitis agenda. It is a joint initiative between World Health Organization (WHO) and the World Hepatitis Alliance.

Francisco Viegas Neves da Silva, Regional Policy Advocacy Consultant, DNDi Latin America, presented on the DNDi strategy on access to hepatitis C treatment.



Advocacy for access to hepatitis treatment

Date: Thursday, November 2, 2017

Chairs: Jennifer Johnston, CEVHAP and Bobby John, Global Health Advocates, India

Introduction and vision
Othoman Mellouk, International Treatment Preparedness Coalition

Advocacy for access for the most vulnerable populations
Luís Mendão, GAT – Treatment Activist Group

Brazilian experience on patent opposition
Felipe de Carvalho, Working Group on Intellectual Property of the Brazilian Network for the Integration of Peoples (GTPI/Rebrip)

DNDi strategy on access to hepatitis C medicines
Francisco Viegas, Drugs for Neglected Diseases initiative

Role of the civil society: case study in a country with access to generics
Rajkumar Nalinikanta, CoNE Manipur

Q&A session



More information: